Skip to content

Comparison of outcomes of multimodality treatment for traumatic acute subdural hematoma: a real-world study

Comparison of outcomes of multimodality treatment for traumatic acute subdural hematoma: a real-world study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075327
Enrollment
Unknown
Registered
2023-09-01
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

traumatic acute subdural hematoma

Interventions

surgery group (surgery):None
Conservative group (Drug):None

Sponsors

Tianjin Medical University General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with acute subdural hematoma within 48 hours of symptom onset or the last medical visit. 2. Access to high-quality baseline and follow-up CT or MRI imaging data ; 3. Age = 18 years.

Exclusion criteria

Exclusion criteria: 1.Patients with severe injuries in other regions, such as the abdomen or chest; 2.Patients in a "moribund" state upon presentation (e.g., bilateral loss of pupillary reflex); 3.Patients with known terminal illnesses resulting in an expected life span of less than 1 year; 4.Patients with severe and progressive dementia or cerebral infarction; 5.Patients who decline to provide informed consent.

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale (mRS) Score;

Secondary

MeasureTime frame
Chronification;cost-effectiveness;

Countries

China

Contacts

Public ContactJiang Rongcai

Tianjin Medical University General Hospital

jiang116216@163.com+86 136 7211 6556

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026